REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Brevnovska Lekarna, S.R.O. (Czech Republic)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Beer, Wine, and Liquor Stores | General Merchandise Stores, including Warehouse Clubs and Supercenters | Professional, Scientific, and Technical Services | Management Consulting Services
Full name: Brevnovska Lekarna, S.R.O. Profile Updated: November 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Brevnovska Lekarna, S.R.O. is based in Czech Republic, with the head office in Prague. It operates in the Pharmacies and Drug Stores industry. Brevnovska Lekarna, S.R.O. was incorporated on October 23, 2013. 10 - 19 (2023) employees currently work for Brevnovska Lekarna, S.R.O..

Headquarters
Belohorska 1665/54
Prague; The City of Prague; Postal Code: 16900

Contact Details: Purchase the Brevnovska Lekarna, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Brevnovska Lekarna, S.R.O. report to view the information.
Registered Capital:
Purchase the Brevnovska Lekarna, S.R.O. report to view the information.
Financial Auditors:
Purchase the Brevnovska Lekarna, S.R.O. report to view the information.
Incorporation Date:
October 23, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Brevnovska Lekarna, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Total operating revenue
-0.74%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo